Gösterilen 1 - 15 sonuçlar arası kayıtlar. 15 sonuç. Aranan kelime 'Mark D. Minden (14961936)', Sorgu süresi: 0.01s
Sonuçları Daraltın
-
1
Data file S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness Yazar: Alex C.H. Liu (14961921)
Baskı/Yayın Bilgisi 2025Diğer Yazarlar: -
2
Data file S3 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness Yazar: Alex C.H. Liu (14961921)
Baskı/Yayın Bilgisi 2025Diğer Yazarlar: -
3
Table S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness Yazar: Alex C.H. Liu (14961921)
Baskı/Yayın Bilgisi 2025Diğer Yazarlar: -
4
Data file S4 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness Yazar: Alex C.H. Liu (14961921)
Baskı/Yayın Bilgisi 2025Diğer Yazarlar: -
5
Data file S2 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness Yazar: Alex C.H. Liu (14961921)
Baskı/Yayın Bilgisi 2025Diğer Yazarlar: -
6
Data file S5 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness Yazar: Alex C.H. Liu (14961921)
Baskı/Yayın Bilgisi 2025Diğer Yazarlar: -
7
Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target Yazar: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi 2025Diğer Yazarlar: -
8
Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target Yazar: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi 2025Diğer Yazarlar: -
9
Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target Yazar: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi 2025Diğer Yazarlar: -
10
Supplementary Table S8 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target Yazar: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi 2025Diğer Yazarlar: -
11
Supplementary Table S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target Yazar: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi 2025Diğer Yazarlar: -
12
Supplementary Table S7 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target Yazar: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi 2025Diğer Yazarlar: -
13
Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target Yazar: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi 2025Diğer Yazarlar: -
14
Supplementary Table S6 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target Yazar: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi 2025Diğer Yazarlar: -
15
Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target Yazar: Ana Vujovic (15207479)
Baskı/Yayın Bilgisi 2025Diğer Yazarlar: